Company Overview and News

to your dashboard

Headline News

Baxter (BAX) Launches Arisure Closed System Transfer Device

2018-01-15 zacks
In a bid to promote safe handling of hazardous drugs and maintain medication sterility, Baxter International Inc. (BAX - Free Report) recently announced a distribution agreement for the launch of the Arisure Closed System Transfer device in the United States. The platform prevents contamination of intravenous (IV) medication delivery system during drug preparation. (59-0)

Frank Magliochetti - On the Increased Incidence of Shingles

2018-01-12 accesswire
LAWRENCE, MA / ACCESSWIRE / January 12, 2018 / "The goal of the Centers for Disease Control and Prevention's immunization programs is to see a reduction in the appearance of a disease, but sometimes just the opposite occurs," states Frank Magliochetti, Parcae Capital's managing partner. With a B.S. in Pharmacy, Frank Magliochetti's participation in Northeastern University's Masters of Toxicology Program provides the foundation for his expertise in pain management and disease control, which is why a 39% rise in Shingles over an 18-year period drew Mr. (38-0)

Blog Exposure - Baxter International Acquires RECOTHROM and PREVELEAK from Mallinckrodt

2018-01-10 accesswire
LONDON, UK / ACCESSWIRE / January 10, 2018 / has just released a free research report on Baxter International Inc. (NYSE: BAX). If you want access to this report all you need to do is sign up now by clicking the following link as the Company's latest news hit the wire. On January 08, 2018, the Company announced that it has a signed an agreement with Mallinckrodt PLC (NYSE: MNK) to acquire two of its hemostat and sealant products - RECOTHROM Thrombin topical (Recombinant) and PREVELEAK Surgical Sealant. (41-0)

BRIEF-Baxter To Acquire Recothrom, Preveleak For Upfront Payment Of About $153 Mln

2018-01-08 reuters

Frank Magliochetti - Discusses Prevention of Colorectal Cancer with NSAIDs

2018-01-06 accesswire
LAWRENCE, MA / ACCESSWIRE / January 6, 2018 / Non-steroidal anti-inflammatory drugs (NSAIDs) may prevent the recurrence of colorectal cancer after surgical removal, says healthcare expert and Parcae Capital founder Frank Magliochetti. A team of scientists from across the United States recently collaborated with Mayo Clinic researchers to determine how well NSAIDs, aspirin and other supplements hinder the development of precancerous or cancerous polyps. (37-0)

A Look at Edwards Lifesciences’ 2018 Sales Guidance

Edwards Lifesciences (EW) expects to generate sales growth of 9%–10% in 2018. This underlying sales growth range is narrower than the company’s dollar sales guidance of $3.5 billion–$3.9 billion. Foreign exchange is expected to have a minimal impact of 0.5% on the company’s total sales in 2018. Peers Boston Scientific (BSX), Abbott Laboratories (ABT), and Baxter International (BAX) expect to generate sales growth of approximately 6. (101-1)

Broadfin Capital, LLC - All Holdings - 13F 13D 13G Filings -

Broadfin Capital, LLC has disclosed 45 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 676,005,000 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Broadfin Capital, LLC's top holdings are Heron Therapeutics, Inc. (NASDAQ:HRTX) , Corium International, Inc. (NASDAQ:CORI) , Retrophin, Inc. (NASDAQ:RTRX) , Horizon Pharma plc (NASDAQ:HZNP) , and Flamel Technologies S. (149-0)

Why This Is the Perfect Level to Buy Celgene Corporation Stock

2018-01-03 investorplace
When investors are looking for high growth and reasonable valuations in the biotech space, Celgene Corporation (NASDAQ:CELG) is one of the first companies to come to mind. However, October was not kind to the CELG stock price. Shares fell more than 35% from the highs. After a slow yet steady bounce, is now the time to buy Celgene? (168-2)

Product Innovation Drives Illumina, Downbeat Margins a Woe

2017-12-27 zacks
On Dec 26, we issued an updated research report on Illumina, Inc. (ILMN - Free Report) . The stock carries a Zacks Rank #3 (Hold). (59-0)

PRA Health (PRAH) Hits 52-Week High on Multiple Positives

2017-12-26 zacks
Shares of PRA Health Sciences, Inc. (PRAH - Free Report) rallied to a new 52-week high of $92 on Dec 22, closing the session nominally lower at $91.53. This represents a strong year-to-date return of approximately 23.9%, higher than the S&P 500’s 6.8%. The stock sports a Zacks Rank #1 (Strong Buy). Taking the stable stock performance into consideration, we expect PRA Health stock to scale new highs in the quarters ahead. (68-0)

Zimmer Biomet Suffers a Dull Knee Business & Supply Delay

2017-12-26 zacks
On Dec 22, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH - Free Report) . The company carries a Zacks Rank #4 (Sell). (75-0)

5 Reasons Why You Should Buy Baxter (BAX) Stock Right Now

2017-12-22 zacks
Baxter International Inc. (BAX - Free Report) is currently one of the top-performing stocks in the MedTech space. Improvement in price performance and strong fundamentals reflect the stock’s bullish run. Therefore, if you haven’t taken advantage of the share price appreciation yet, it’s time you add the stock to your portfolio. (42-0)

Tailored Brands, Motorcar Parts of America, Cadence Design Systems, Red Hat and Splunk highlighted as Zacks Bull and Bear of the Day

2017-12-21 zacks
Chicago, IL – Dec 21, 2017 – Zacks Equity Research highlights Tailored Brands (TLRD - Free Report) as the Bull of the Day and Motorcar Parts of America (MPAA - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on the Cadence Design Systems, Inc. (CDNS - Free Report) , Red Hat, Inc. (RHT - Free Report) and Splunk Inc. (SPLK - Free Report) . (80-0) highlights: Accenture, Applied Materials, International Consolidated Airlines Group, Microchip Technology and CBRE Group

2017-12-21 zacks
Chicago, IL – Dec 21, 2017 - Stocks in this week’s article include: Accenture plc (ACN - Free Report) , Applied Materials, Inc. (AMAT - Free Report) , International Consolidated Airlines Group, S.A. (ICAGY - Free Report) , Microchip Technology Incorporated (MCHP - Free Report) and CBRE Group, Inc. (CBG - Free Report) . (179-0) highlights: G-III Apparel Group, Michael Kors Holdings, Magellan Health, Boston Beer and FTI Consulting

2017-12-21 zacks
Chicago, IL – Dec 21, 2017 - Stocks in this week’s article include: G-III Apparel Group, Ltd. (GIII - Free Report) , Michael Kors Holdings Ltd. (KORS - Free Report) , Magellan Health, Inc. (MGLN - Free Report) , Boston Beer Company, Inc. (SAM - Free Report) and FTI Consulting, Inc. (FCN - Free Report) . (72-0)

CUSIP: 071813109